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ABSTRACT
SIMULATION ANALYSIS MODEL FOR MAGNETIC DRUG DELIVERY TO THE
TARGETED TUMOR USING EXTERNAL MAGNETIC FIELD

Vishnu Priyanka Kadiriboina, M.S.
Department of Mechanical Engineering
Northern Illinois University, 2016
Dr. Pradip Majumdar, Director
The difference between success and failure of chemotherapy depends on not only on
the drug itself but also how it is delivered to its target. In current research Magnetic Drug Targeting
(MDT) plays an important role in effective drug delivery. Super para-magnetic Nano-particles
filled with drug are used as a delivery system for anti-cancer agents in loco regional tumor therapy
called magnetic drug targeting. The cancer loco regional tumors are identified and super
paramagnetic particles are applied intra arterially close to the tumor region and focused to the
tumor by a strong external magnetic field. With the injection of the magnetic drug particles in the
blood stream, an external high-gradient magnetic field is applied in order to pull and create higher
concentration concentrate at a specific target tumor site. In this study a three-dimensional
computational simulation model for MDT is developed based on coupled blood flow dynamics
and mass species transport in a blood flow artery network with externally applied magnetic field
at the local target region. The main objective is to evaluate the effectiveness of the MDT method
in delivering the drugs to the internal targeted tumor region. Further, the MDT method is optimized
for the key process parameters such as particle size and the magnetic field parameters.
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1 INTRODUCTION
1.1 Magnetic Drug Targeting
Magnetic drug targeting is a method of delivering drug to the effected tumor in the body.
This MDT technique can enhance the relevance of certain medical treatments (J. W. Haverkort,
2009). In conventional drug delivery system, the drug is administered by intravenous injection, it
then travels to the heart from where it is pumped to the other parts of the body. This leads to larger
doses of the drug and extremely inefficient. The targeting of the drug to the specific area can be
significantly enhanced by attaching the drugs to magnetic particles. Injecting these magnetic
particles into blood stream and using a high gradient magnetic field to pull them out of suspension
in the target region. The particles were surrounded with a hydro glucose polymer to stabilize the
magnetic particles under various physiological conditions (Lübbe AS, 1996). Once on the vessel
wall the drug can be either released directly onto the blood stream or biological technique will be
used to take up particles into tissues.
In previous studies the magnetic drug delivery technique has considered as tracking individual
particles under the influence of stokes drag and magnetic force alone. Here we also consider
interactions and collisions between moving red blood cells in the blood stream which causes a
diffusive motion of the magnetic particles much greater than the standard Brownian diffusion. We
formulated a 3-D model, suitable for studying the deposition of drug concentration within a
network of the blood vessel.
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The motion of the magnetic particles in the blood stream is modeled as advection- diffusion
model. In this study the drug concentration of the magnetic particles is near the tumor is maximized
and the total flux deposited along the lower blood vessel wall is maximized.

1.2 Literature Review
Andrew D. Grief et.al, (2005) A mathematical model for targeted drug delivery using
magnetic particles is developed. This includes a diffusive ﬂux of particles arising from interactions
between erythrocytes in the microcirculation. The model is used to track particles in a vessel
network. They developed advection diffusion model for the concentration magnetic particles
which includes interactions and collisions between moving red blood cells. They proposed
equations for Brownian diffusion, shear diffusion and particle convection. The constant values for
aspect ratio, shear peclet number, Brownian peclet number, and dimensionless magnetic velocity
for a human artery model are used from this paper.
KrishanuNandy et.al, (2007), proposed an analytical technique that describes the
magnetophoretic transport of magnetic microspheres under an imposed magnetic field when there
is pressure driven flow through micro channel. The analysis shows that the capture efficiency is
the function of two independent non-dimensional parameters which are in turn involve all the
physical design and operating parameters of the microfluidic separator.
Haverkort, J. W et.al, (2009) describes the manipulation of the magnetic particles in a
continuous flow with magnetic fields. They simplified a two dimensional equation for the motion
of particles in Poiseuille flow is considered for various magnetic field configurations. Exact
analytical solutions are derived for the particle motion under the influence of a constant
magnetization force, drag force, lift forces and gravity forces. They derived expression for the
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dimensionless “particle magnetization number’. The capture efficiency of the particles depends on
the magnetization number.
Yue P., et.al (2011) developed a three dimensional model for the motion of super
paramagnetic cluster suspended in a Poiseuille flow and guided by an external magnet to travel to
a target. Variation in the release position, background flow, magnetic field strength, and number
of clusters are assessed. The given magnetic equations for dipole strength, magnetization and
magnetic field. They considered the motion magnetic particles in blood stream under stokes drag
force, magnetic field and gravity force. They derived equation of motion of the magnetic particles
and from that the velocity of the particles in a three dimensional model.
Haverkort H.W., et.al (2009) Computational simulations are performed of blood flow and
magnetic particle motion in a left coronary artery and a carotid artery, using the properties of
presently available magnetic carriers and strong super conducting magnet.
Dobre. Aet.al (2010) reported a numerical study on the blood-magnetic carrier aggregate
flow in the external magnetic field for magnetic drug targeting. They performed numerical
simulations on more realistic, complex and patient related arterial system morphology. They
performed numerical simulation on COMSOL for flow (blood) is assumed as Newtonian,
incompressible and laminar. The data sets of 2D scans, Digital imaging and communications in
medicine (DICOM) format provide information to generated arterial tree which is used for
numerical study. They used segmentation tool for isolating blood model from imported image.
The 3D final models are adjusted with smoothing filters. They computed deformation of the
muscular volume and the walls under the pressure of the flow for several moments of the quasisteady flow regime.
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1.3 Objective
Objective of this study is to model a simulation model for magnetic drug delivery to the
targeted tumor using external magnetic field. The main objective of this study is to analyze the
amount of drug delivered to the targeted tumor under high gradient magnetic field. The blood is
assumed to be a Newtonian, incompressible, time dependent and laminar one. The arterial wall is
designed in CREO 2.0 as a variable diameter with a branch leading to small branch. Navier-stokes
equation is solved for pulsating blood flow velocities along the branch with the given boundary
conditions using COMSOL software. The tumor in the body is targeted and near the tumor high
gradient magnetic field is generated to pull them out of suspension using neodymium super
conducting permanent magnet. Advection-diffusion model is used to consider the collisions and
interactions between moving red blood cells in the blood stream which cause diffusive motion of
the magnetic particles. The mass conservation of blood is computed near branch. The amount of
drug delivered using advection and diffusion is computed at different time steps.

2 CANCER TUMORS
2.1 Introduction
"Tumor, also known as a neoplasm, is an abnormal mass of tissue which may be solid or
fluid-filled" (MNT, 2014). Tumor resistance to chemotherapy remains a major challenge, because
it results in unnecessary toxicity and costs and, most importantly, delay in initiating potentially
more effective treatment. In the last decade, there has been growing interest in molecular imaging
for tumor response monitoring at an early stage during treatment (A. A. M. Veldt 2010). Tumors
will be of two types. One is benign tumor and the other is malignant tumor. Benign tumors are not
harmful. Benign tumors don’t spread and stay in one place. Benign tumors are curable once they
are removed by surgery and they will not grow back generally. Malignant tumors are called cancers
and are harmful. Cancer is a name of a group of many diseases. Mainly, when a cell in a part of
the body grows abnormally and goes out of control, it is called a cell converted to a cancer cell. It
changes its DNA and starts growing instead of dying. This cancer cell has the ability to affect the
other tissues and invade them to make them cancer cells. These cells amalgamate to form
malignant tumor which is enough wild to damage the all other tissues around them (Haritha G.,
2015).
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The difference between the two tumors has been schematically represented in the Fig 2.1.

Fig2.1Types of Tumors

2.2 Statistics of Cancer
The estimation of population all over the world, affected from different types of cancer
tumors are listed below in fig 2.2, which explains about the 5-year prevalent cancer cases, adult
population

Fig 2.2Statistics of People affected by cancer tumors all over world
The statistics show that over 15% of world population is affected by cancer tumor as of
2012 but there is estimation that it may cross 33% by 2020. Among all the countries in world
USA has major percentage of population suffering from cancer. Women are mostly affected by
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breast and ovarian cancers. The statistics shows that 29% of men and 24% of women die from
cancer in Canada. 45% of men and 42% of women will diagnose with cancer in their life time.

2.3 Methods of Cancer Treatment and Side effects
As the number of people diagnosed by cancer is increasing drastically year by year, all
over the world, much research is taking place to invent new technology for cancer treatment.
The main objective of the treatment is to kill cancer tumors or remove cancer tumors
without any side effect to the other parts of the body and even it is very important that cancer
tumors should not grow in time span. Looking forward, we have following methods for the
treatment of cancer tumors.
 Radiotherapy
 Surgery
 Chemotherapy
 Immunotherapy
 Targeted therapy
Side Effects of the treatments
The type of treatment depends on the patient medical condition. Not every person who
went through the treatment will withstand the radiations, chemicals, heavy dose drugs etc. Chemo
includes nausea and vomiting, loss of appetite, loss of hair and mouth sore. During chemotherapy,
for example, typically less than 0.1 to 1% of the drugs are taken up by tumor cells, with the
remaining 99% going into healthy tissue (Aleksandar Nacev, 2013).
The main objective for any treatment is to focus the disease locations in the human body.
In cancer treatment it is very crucial to focus on the tumors. In many cancer treatments like
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chemotherapy very low amount of the drug is delivered to the tumors because major portions of
the drug are delivered to the healthier tissues. Chemotherapy may cause side effects to the patients
because they use diverse collection of drugs and the dosage of the drug for this treatment is selected
by how much patient can be withstand instead of killing the tumors. Even chemotherapy effects
bone marrow, skin, hair, gut and immune system cells.
Magnetic drug targeting (MDT) is the process of attaching the drugs to magnetic particles
and applying the magnetic field near the tumor locations in order the deliver the drug to tumor
locations. The targeting of drugs to a specific region of the human body can be significantly
enhanced by attaching the drugs to magnetic particles (J. W. Haverkort, 2009). In MDT the
magnetic particle clusters filled with the cancer therapeutics and injected into the artery and the
tumor location is carefully positioned near strong magnetic fields. These injected magnetic drug
particles are strongly influenced by the external magnetic field strength inside the body. The
magnetic force that the particles experience is relatively insensitive to the bio-chemical
environment and other physical forces such as electrostatic, surface tension and Brownian
important in micro-scale (Ranjan Ganguly and Ishwar K. Puri, 2010).
The magnetic particles are effectively controlled inside the human body. Magnetic micro
and nano-particles have gained a lot of interest during the last decades, due to a wide field of
possible applications (D. Kappe, A. Hütten, 2012). Fig 2.3 shows the physical setup of magnetic
drug targeting technique.
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Fig2.3Magnetic Drug Targeting Technique
The ultimate goal of magnetic drug targeting is to direct therapeutics to deep tumor cells
within the body. The above figure shows the principle of MDT and the set up for treatment. Ferro
fluids have become the primary carriers due to their high saturation magnetization and magnetic
susceptibility for magnetic targeting drug delivery (Shashi Sharma, 2014). The stability of the
magnetite and carbohydrate will greatly impact on what fraction of the adsorbed drug is available
for targeting to the tumor (Andreas Stephan Lübbe, 1996). Much research is developing on the
existing magnetic material properties to enhance the efficiency of this technique. Recently
superconducting magnets are also used for MDT technique. Next challenge of MDT technique is
to optimize intratumoral magnetic particle concentration, several features need to be considered:
(a) the particles should be of a size that allows sufficient attraction by the magnetic field and their
introduction into the tumor or into the vascular system surrounding the tumor; (b) the magnetic
fields should be of sufficient strength to be able to attract the magnetic Nano-particles into the
desired area; (c) the FF complex should deliver and release a sufficient amount of anticancer agent;
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and (d) the method of injection should have good access to the tumor vasculature and should avoid
clearance by the reticuloendothelial system (“first pass effect”) (Alexiou C, 2013).

3 COMPUTATIONAL MODEL
A detailed description of the computational model is explained in this chapter. Artery
geometry, computational mesh, boundary conditions are given in this chapter.

3.1 COMSOL Multiphysics software
The application of computational techniques in the investigation of the blood flow in
arteries has become an important tool due to its ability to simulate velocity and pressure fields in
virtual models of the cardiovascular system. COMSOL is commercial multi-physics software
where we can perform analysis on different physics. COMSOL is very advanced software with are
predefined equations. The single phase laminar flow simulations of blood flow became an
important tool to find the cardiovascular functionality. Multi-physics studies go further by
visualizing the flow, WSS mass transport, shear distribution and magnetic field regions which is
difficult to describe using experimental techniques. The objective of the study is to find the amount
drug delivered to the targeted area in the Newtonian blood when it goes through capillaries under
strong external magnetic field. The most important character in blood flow is its unsteadiness, the
computational model that is developed must be able to compute complex gradient of velocities
that vary extremely along the cardiac cycle. Considering all these complex characteristics of blood
and arteries in multi-physics software is not an easy task.
In this study CFD simulations were carried out by considering blood as Newtonian and
Non Newtonian. The viscosity for Newtonian nature of the blood is constant 0.0035 Kg/s.
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The density of 1050Kg/m3.Navier-stokes equation is used to solve the velocity of the blood
in artery. Simulations were carried over a period of pulse cycle of 5 sec. The femoral artery
diameter is taken as 8mm with a length of 12cm with branch of 6mm diameter and a tumor of 6mm
diameter is considered under the blood vessel at a distance of 20mm is targeted to deliver the drug.
A 3-dimensional computational model of femoral artery with sub branches and muscle medium is
developed using commercial 3D CAD software CREO 2.0 this model is imported into COMSOL
multi-physics 4.4 version software.
In COMSOL for analysis we performed three physics individually for simulation of the
blood flow velocity along the blood vessel single phase laminar flow analysis is done. PARDISO
solver is used for computing the results. The magnetic field is generated under tumor using
magnetic fields physics in COMSOL. The advection and diffusion model is generated for
analyzing amount of drug delivered to the targeted area.

3.2 Laminar Flow-COMSOL Physics
The blood flow is considered as single phase laminar flow. The laminar flow, also known
as streamline flow which generally occurs when fluid flows in parallel layers. The flow occurs in
closed pipes at low velocities. The blood flow is assumed as incompressible, laminar, Newtonian
flow (Alexandru M, 2010). The velocity field for this flow is solved by Navier-stokes equation.
The Navier stokes and mass momentum equations are given below
𝜌(

𝜕𝑢
𝜕𝑝
+ 𝑢. ∇𝑢) = −
+ ŋ∇2 𝑢
𝜕𝑡
𝜕𝑥

Mass conservation equation is
𝜕𝜌
= −𝜌∇. 𝑢
𝜕𝑡
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For steady state
∇. 𝑢 = 0

3.2.1 Newtonian Fluid
Newtonian fluids are the one which obey newton’s law. In Newtonian fluid the shear
stress is directly proportional to shear rate and the constant of proportionality is coefficient of
viscosity. Blood acts as Newtonian fluid in larger arteries.
i) Shear stress is proportional to rate of shear strain in fluid
ii) Stress to rate of strain is isotropic
𝜏 =𝜇∗𝛾
𝜏=Shear stress
𝜇= Viscosity
𝛾=Shear rate

3.2.2 Non Newtonian Fluid
These are the one which do not obey newton’s law. In this shear stress is not linearly added
because viscosity varies. In small arteries and capillaries blood acts as Non Newtonian fluid which
helps in passage of Small cells (RBC, WBC) suspended in the blood.

3.2.3 Flow conditions: Femoral artery waveform
The waveform used in the analytical and CFD solution is obtained from the waveform
generated (Junichiro Hashimoto and Sadayoshi Ito, 2013). This waveform is generated by the 16
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sec data of the femoral flow velocity interpolated offline for every 10ms and plotted against time
using Mathematica Software. The beat-to-beat pulse waveform was ensemble-averaged for 10
cardiac cycles (i.e. 10 pulses).
Systolic forward peak velocity (Vf)
Diastolic reverse peak velocity (Vr)
End diastolic velocity (Vd)
Time-averaged mean velocity (Vm)

Fig 3.1Femoral artery wave form
From the averaged waveform the parameters in terms of flow velocity and the other
relevant data extracted from the wave form is explained below, and the generated waveform is as
shown in the figure 3.1(Shafiullah Mohammad and Pradip Majumdar,2013).
The femoral flow velocity increased rapidly in early systole and reached peak velocity (Vs)
and it reduces gradually to the minimum reverse velocity (Vr). The deceleration time is
comparatively shorter than the acceleration time. The amplitude of the reverse flow velocity is
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smaller than the forward flow velocity and greater than the diastolic flow velocity (Shafiullah
Mohammad and Pradip Majumdar, 2013).
3.2.4 Calculation of Velocity profiles
The solution for homogeneous, incompressible, Newtonian fluid flow in a rigid, cylindrical
tube was proposed by Hale, McDonald and Womersley in 1955.
The cardiac cycle is a periodic phenomenon. Any flow property which is periodic in time
can be expressed as the sum of a Fourier series of form.
𝑑𝑝
= − Â (𝜔)𝑒 𝑖𝜔𝑡
𝑑𝑧
This is periodic in time with frequency ω.
From the above pressure the velocity can be derived as:
3

𝑢(𝑟, 𝑡) =

Â
i

{1 −

r

Jo (i2 α R)
3
2

}𝑒 𝑖𝜔𝑡

Jo (i α)

Where α is the Womersley parameter, R is the radius of the pipe, ρ is the density of the
fluid (Shafiullah Mohammad and Pradip Majumdar, 2013).

3.3 Magnetic Fields: Maxwell’s Equations for the Magnetic Field
Electromagnetic fields are classically described by Maxwell’s equations. The magnetic
field in our application is quasi-stationary or slowly varying, magnetic fields. The solution for
quasi-stationary magnetic field is given as.
∇×H= j
The vector potential A is given by
B= ∇×A
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The constitutive equations given by ohm’s law are
j = σE
B = μH
D = εE
It is proved that when materials subjected to magnetic field H, additional magnetic field
component M is generated locally and together will give total local induction
B = μ0 H + μ0 M = μ0 μR H
We can write this as

𝑀 =ᵡ𝐻
ᵡ = 𝑚𝑎𝑔𝑛𝑒𝑡𝑖𝑐𝑠𝑢𝑠𝑝𝑒𝑡𝑎𝑏𝑖𝑙𝑖𝑡𝑦=0.2

H=

1

*

𝑚

2𝜋 𝑒 3

The dipole moment is denoted by m & e is the vertical distance of the tumor from the
blood vessel.
The force on the magnetic body in an external field is given by
𝑉

𝐹𝑚 = ∫ 𝜇0 (𝑀. ∇)𝐻𝑑𝑉
𝑉

The force equation is given by
𝐹𝑚 = 𝑉

3𝜇0 ᵡ
(𝐻. ∇)𝐻
3+ᵡ

Here B is the magnetic field [T], H is the magnetic intensity [A/m], j is the current
density [A/m2], M is the material magnetization [A/m],ᵡ𝑚 is the magnetic susceptibility, and is
the permeability of a vacuum [ N/A2] (Somna Mishra,2008), (Yue, P,2011).
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The Maxwell equations hold well in vacuum, materials, permanent magnets for
magnetization, and in electromagnets for current generation. The propagation of the MagneticNano-particles inside the body will not change because the magnetic susceptibility of the tissue
is very negligible. On the other side magnetite cores have magnetic susceptibility of 5-7 orders of
high magnitude hence these magnetic particles are strongly influenced by magnetic fields (R. E.
Rosensweig, 1985).

3.4 Species Transport
3.4.1 Advection and Diffusion Model:
3.4.1.1 Diffusion Forces
The motion of magnetic particles in a blood vessel is occurred due to diffusion flux and
advection flux. The behavior of such particles in-vivo is complex and governed by blood
convection, diffusion (in blood and tissue), extravasation and the applied magnetic fields (A.
Nacev,C. Beni, 2011). The velocity of the magnetic particles in the blood vessel is balanced by
stokes drag force and magnetic force. Diffusion occurs due to two mechanisms within the blood
vessel Brownian and shear. The overall diffusion is the sum of Brownian diffusion and shear
induced diffusion. Both chemical and physical effects of red cells have been implicated in the
spontaneous aggregation of platelets in sheared whole blood (WB) (H. L Goldsmith, 1995). The
shear induced Brownian motion occurs due random motion of the particles under thermal
fluctuations it is defined by Brownian diffusion coefficient (Grief, A. D, 2005). The diffusion
coefficient relates diffusive flux with the particle concentration gradient (Aleksandar Nacev,
2013).
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𝐽𝑑𝑖𝑓𝑓 = −𝐷∇𝑐

DBr =

k∗T
= 6.34 ∗ 10−15 m2 /s (at T = 300 c)
6∗π∗μ∗a

D = K sh (rRBC )2 ∗ γ +

k∗T
= Dsh + DBr
6∗π∗μ∗a

Where
Dsh = shear diffusion = 6 ∗ 10−11 𝑚2 /𝑠 [11]
K

= Boltzmann’s constant =1.3806488 × 10-23 m2 kg s-2 K-1

µ = viscosity of the blood = 0.035 pa-s

a

= radius of the particle = 1*10^-6 m

D= 6.0006*10^-11 m^2/s

3.4.1.2 Advective flux
The blood velocity profile in the blood vessel is highest at the center and gradually
decreases to zero at the walls his is due to no-slip boundary condition. For Newtonian fluid the
shear rate is linear but as blood is nonlinear the shear rate is nonlinear and entirely depends on
the viscosity model. The shear diffusion tends the magnetic particles to aggregate at low shear
rates. The advective flux is given the following equation
𝐽𝑎𝑑𝑣𝑒𝑐 = 𝑐 ∗ 𝑣𝑝
c = Particle concentration
𝑣𝑝 = Particle velocity
𝑣𝑝 = 𝑣𝑏 + 𝑣𝑚𝑎𝑔

19

The magnetic particle velocity in the blood vessel is sum of the fluid velocity and
magnetic velocity. The velocity of the particles varies in x, y & z components. The governing
equation for the particle concentration including convective flux and diffusive flux is given by
following relation (Grief, A. D, 2005).
𝜕𝑐
𝜕𝑡

+ ∇. (𝑐𝑣𝑝 )= ∇. (𝐷∇𝑐)

These can be derived relating the flux of particles onto the boundary of the blood vessels
to the evolution of the surface density of particles on the vessel wall,𝜎(𝑥, 𝑡)
𝜕𝜎
𝜕𝑡

= 𝑛. [𝐽𝑎𝑑𝑣𝑒𝑐𝑡 + 𝐽𝑑𝑖𝑓𝑓 ] boundary

= 𝑛. [𝑐𝑣𝑚𝑎𝑔 − 𝐷∇𝑐]𝑏𝑜𝑢𝑛𝑑𝑎𝑟𝑦

The dimensionless version of the

𝜕𝑐 3
𝜕𝑐
𝜕
𝜕
𝛼
𝜕
= ∗ (𝑦 2 − 1)
−
((𝛼𝑓. 𝑥)𝑐) −
(( 𝑓. 𝑦) 𝑐) −
𝜕𝑡 2
𝜕𝑥 𝜕𝑥
𝜕𝑦 𝛿
𝜕𝑧
+

1 𝜕 2𝑐 1 𝜕2𝑐 1 𝜕 2𝑐
1
𝜕 2𝑐 1 𝜕
𝜕𝑐
( 2 + 2 2 + 2 2) +
(⃒𝑦⃒ 2 + 2
(⃒𝑦⃒ )
𝑃𝑒𝐵𝑟 𝜕𝑥
𝛿 𝜕𝑦
𝛿 𝜕𝑧
𝑃𝑒𝑠ℎ
𝜕𝑥
𝛿 𝜕𝑦
𝜕𝑦

+

1
𝜕𝑐
(⃒𝑦⃒
))
𝛿2
𝜕𝑧

Where

PeBr =
PeSh =

6∗Ub ∗L∗μ∗π
k∗T

=1.6785*10^12= Brownian peclet number

L∗d
3∗Ksh ∗rRBC 2

= Shear peclet number
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δ=

α=

d
= aspect ratio
L
Fm
6∗π∗μ∗a∗ub

= dimension less magnetic velocity

Estimates for these constants for a particle of diameter 2a for artery are given as
1
= 8.7 ∗ 10−6
PeBr ∗ δ2
α
= 1.6 ∗ 10−3
δ
f = unit force vector
The flux of the particles can be computed by integrating over the length of the blood vessel
𝑑𝑒𝑝𝑜𝑠𝑖𝑡𝑒𝑑

𝑞𝑖𝑗

𝐿

𝑖𝑛
= min(∫0 𝑖𝑗 𝑐𝑖𝑛 ∗ 𝑣𝑚𝑎𝑔 . 𝑛𝑖𝑗 𝑑𝑙, 𝑞𝑖𝑗
)
𝑑𝑒𝑝𝑜𝑠𝑖𝑡𝑒𝑑

𝑜𝑢𝑡
𝑖𝑛
𝑞𝑖𝑗
=𝑞𝑖𝑗
− 𝑞𝑖𝑗

These are considered for a branch of the blood vessel with different dimensions.

3.5 Artery Geometry
In order to study the accurate blood flow dynamics in the femoral artery the artery geometry
should be a representative of the native anatomy. The geometry of the femoral artery with the sub
branches was constructed in solid works based on the average dimensions (Shafiullah Mohammad
and Pradip Majumdar, 2013). The malignant tumor is targeted at some distance from blood vessel.
The main objective of this thesis is to analyze the amount of drug delivered to this tumor by
coupling the magnetic velocity to the drug convective velocity.
The healthy femoral artery was designed by taking 120mm of length and 8mm diameter
with a branch of diameter 6mm to the main artery. An additional sub branch of diameter 5mm is
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attached to the branch. The permanent magnet is created below the tumor to generated strong
magnetic field near the tumor. The copper coil is created around the permanent magnet to
generated magnetic field the wire carries current. The muscle is assumed as the interface between
the artery and the tumor, air is the medium of interface between the permanent magnet and the
artery surface.
3.5.1 Healthy Artery
The generalized geometry model of the healthy artery is as shown below. The length of the
straight artery is 120mm and with a fixed diameter of 8mm and a branch of 5mm diameter is
designed in solid works. The geometry of the healthy straight artery is as shown in the figure (3.2).
8mm

120mm
m
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Fig 3.2Blood Vessel geometry
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Fig 3.3 The geometry of the blood vessel and tumor with other air and muscle
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Table 3.1Properties used in the physics
Blood
Viscosity

Magnetic fields

0.035 Pa-s

Magnetic

Species Transport

0.2

Drug particles

Magnetite

1 A-m^2

Inlet

0.01 mol/m^3

susceptibility
Density

1070 kg/m^3

Magnetic
Dipole

concentration

moment(m)
Radius of

3mm

vessel

Magnetic

1

*

𝑚

2𝜋 𝑒 3

Field

Molar mass

231.526

Of magnetite

g/mol

Strength(H)
Length of

120mm

Magnet

Neodymium

Diameter

2*10^-6m

Density

7400kg/m^3

Density

5150Kg/m^3

blood vessel

3.5.2 Geometry Mesh
The base size of 0.4mm with 3 prism layers, and with a prism layer thickness of 25% of
the core and medium temporal growth is selected.
The generated mesh for healthy artery and tumor with muscle is shown in the Figure 3.4.
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Fig 3.4Mesh generation for the blood vessel

4 RESULTS AND DISCUSSIONS
4.1 Laminar Flow Physics
Initially the data for the cardiac cycle is taken from the Mathematica software using the
equation discussed in chapter 3.

Fig 4.1 The cardiac cycle plotted velocity against time

Fig 4.2 Blood vessel at different sections
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The cardiac cycle profile we plotted against the data is shown in Fig 4.1. The sections we
assumed to plot along the blood vessel are shown in Fig 4.2.
The cardiac cycle profiles are plotted against velocity along the artery. For this timedependent study with velocity inlet and pressure outlet boundary conditions were applied.

Fig 4.3Variation of centerline velocity along straight (left) and branched (right) arteries are
plotted
The figure 4.3 shows the progressive increase in center line velocity with increase with the
length of the pipe and approaches a constant centerline velocity, representing a fully developed
flow condition. Near the branch there is a steep decrease in the velocity and remains constant.
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Fig 4.4 Axial velocities plotted against arterial diameter at different locations
The axial velocities plotted against the different locations are shown in the Fig 4.4. The
axial velocity profiles are plotted at different sections for given time. It shows that velocity profiles
at same time are different at different cross sections, this is because of the blood has high Reynolds
number during systole and later it decreases.

At x=85

Fig 4.5 Axial velocity plots at peak systole and at diastolic reverse peak (Vr) different cross
sections
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The Fig 4.5 shows the axial velocity plotting at peak systole and at diastole reverse peak at
different sections. In this study the analysis is concentrated on six different time steps along the
different phases of the cardiac cycle: Acceleration phase (0.04sec), Peak systole (0.14-0.17sec),
deceleration phase (0.2sec), minimum velocity point (0.27sec), diastolic peak (0.5sec) and
diastolic phase (0.76sec).

Fig 4.6 Maximum velocity at forward systole t=0.14s.
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Fig 4.7 Minimum velocity at reverse systole Vr=0.27s
FiFI

Fig.4.8 Diastolic peak velocity at t=0.5s
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Fig 4.9Enlarge view of the branch at t=0.14s
From the Fig 4.6, 4.7, 4.8, 4.9, it can be concluded that the flow patterns are highly varying
along the cardiac cycle. The flow at the entrance of the branch shows the occurrence of flow
separation. We can observe the maximum velocity at the wall before the branch is high during the
systole period and reduces gradually during the diastolic period of flow, forming the flow
separation region at the branch entrance.
4.1.1 Pressure Variations
The pressure variation along the artery are shown at different time steps the figures
conclude that the pressure variation may change high to low and low to high at different pulses.The
pressure variations are observed during the cardiac cycle period and remains constant during entire
time span of 5seconds.The figure concludes the the blood flows from high pressure inlet to low
pressure outlet and the pressure increases at the outlets as blood pumps for cardiac cycle time.
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Fig 4.10 Pressure at t=0.1s

Fig 4.11Pressure at At t=0.2s

Fig 4.12 Pressure at t=1.4s

Fig 4.13 Pressure at t=0.1s
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Fig 4.14 Pressure plots along center of the blood vessel(left) along branch (right).
Fig 4.10, 4.11, 4.12, 4.13 shows pressures at different times. Strong pressure variations are
observed for cardiac cycle and then pressure remained at relatively low level during remaining
part of the cardiac cycle along the blood vessel. Fig 4.14 shows pressure plotting at center and
along the blood vessel.
4.1.2 Shear Rate
The Wall Shear Stress (WSS) acting on the arterial walls is plotted against the length of
the artery. Shear stress plots at each time steps selected are shown in the figure 4.8. Shear rate is
proportional to shear stress with a viscosity constant. It is the ratio of velocity and distance. Shear
stress varies from zero at center to maximum at walls.
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Fig 4.15 Shear rate at t=0.14s

Fig 4.16Shear rate at t=0.26s
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From the Fig 4.15, 4.16, we can conclude that the shear rate is maximum at walls and
gradually decreases to the center of the blood vessel.

Fig 4.17Shear rate variation at center

Fig 4.18Shear rate variation at wall
Shear rate variation along the vessel walls and at the center of the blood vessel is shown in
Figure 4.17, 4.18. It can be observed that maximum shear is at wall and minimum is at center of
the blood vessel.
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4.2 Magnetic Fields
The magnetic flux density, B (T) and magnetic field intensity (A/m) generated along the
blood vessel using the relations discussed in chapter 3. The magnetic dipole moment is the input
parameter for the field generation. The dipole moment is the variable which effects magnetization.
Therefore, the magnetic flux density and magnetic field intensity varies with the dipole moment
values proportionally. The figure 4.10 shows the magnetic flux density at different locations.

Fig 4.19 Magnetic FluxDensity,B(T)at bottom of the tumor
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Fig 4.20B(T) at center of tumor

Fig 4.21 B(T) at center of blood vessel
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Fig 4.22B(T) at top of the tumor.
From Figure 4.19, 4.20, 4.21, 4.22 we can conclude that the magnetic flux density is
maximum at the bottom of the tumor and gradually decreases as the distance of the object from
the magnetic surface increases. Maximum flux density is obtained at bottom of the tumor
8.57*10^-4 T.

Fig 4.23 Magetic Flux densiy B(T) @ m=5A/m^2
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Fig 4.24 Magnetic Flux density B(Tesla) @m =10A/m^2

Fig 4.25 Magnetic Flux density B(Tesla) @ m 25A/m^2
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Fig 4.26Magnetic Flux densityB(Tesla) @ m 50A/m^2.
Manetic flux density variation for each dipole moment can be observed from the Figs 4.23,
4.24, 4.25, 4.26.
The variation of magnetic flux density and field strength along the blood vessel is shown
below :

Fig 4.27 Magnetic field strength H(A/m) along the blood vessel at different dipole momemts
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Fig 4.28 Magnetic flux density along the blood vessel at different m(A/m^2).

From above Figures 4.23 - 4.28 we can conclude that the magnetic flux density is maximum
around the tumor location under the blood vessel. As the magnetic dipole moment increases then
the flux density and field strength generated are incresed proportionately. Magnetic flux density is
also varies with dipole as discussed. Fig 4.27 shows the variation of flux density(B Tesla)and field
strength (H A/m).
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Fig 4.29 Variation magnetic flux across the tumor .
The variation of magnetic flux density across the tumor is shown in Figure 4.29. Maximum
magnetic flux is produced at the bottom of the tumor as it is near to the permanent magnet.

4.3 Species Transport without Magnetic Fields
The drug concentration is inleted into the blood vessel with drug and blood concentration
ratio of 1:10. The magnetite particles are inleted into the blood vessel as they have high magnitudes
of magnetic susceptibility .The concentration along the blood vessel is shown in Fig 4.30 with out
any external magnetic field acting on the drug particles.The drug particles are moving with fluid
velocity in the blood vessel. There is no external force is acting on the drug particles to drag the
particles to a specific area.
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Fig 4.30Concentration of drug along the blood vessel at t=2s

Fig 4.31Concentration at t=5s
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Fig 4.32 Concentration of the drug along the arc length(mol/m^3)

Fig 4.33 Convective flux magnitude (mol/m^2*s) of the drug along arc length

Fig 4.34 Total flux magnitude (mol/m^2*s) of the drug along the arc length
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Fig 4.35Diffusive flux magnitude(mol/m^2*s) of the drug along arc length.
The variation of conentration ,total flux, convective flux and diffusion flux along the blood
vessel are shown in the figure 4.32, 4.33, 4.34, 4.35. The above figure shows the drug concentration
along the blood vessel without magnetic field strength at the targeted area. The drug particles are
uniformly distributed along the blood vessel. In this case the drug is diffusing into the healthier
tissue which effects their regular functioning.

4.4 Species Transport With Magnetic Fields
In this case the external magnetic field strength is acting on the drug particles to drg the
partcles to the targeted area. The magnetic field strength and field force euations are discussed in
chapter 3. In section 4.2 we discussed the variation of magnetic filed stregth across the tumor.
The following are the results obtained for drug concentration, convective flux, diffusive flux and
total flux under magnetic field strength.
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Fig 4.36 Concentration of the drug along blood vessel (mol/m^3) at time step(t) 1 sec

Fig 4.37 Concentration of the drug along the blood vessel (mol/m^3) at time step (t) 5 sec
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Fig 4.38 Convective flux(mol/m^2*s) along the blood vessel at t=5 sec

Fig 4.39 Diffusive flux (mol/m^2*s) along the blood vessel t=5 sec
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Fig 4.40 Total Flux (mol/m^2*s) along the blood vessel at t=5 sec.
From the above figures 4.36, 4.37, 4.38, 4.39, 4.40 we can observe that the maximum
amount of the drug is deposited around the tumor where external magnetic field is created which
acts as an external force on the drug particles to deposit around the tumor by which the we can
enhance the drug utilization near the targeted area and reducing the effect of the drug on healthy
tissues.
The following figures shows the variation of drug concentration along the blood vessel in
graphical method.
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Fig 4.41Concentration(mol/m^3) variation along the blood vessel under external magnetic field
strength at different time steps t ( sec).
The Fig 4.41 shows that maximum drug concentration is deposited near targeted area under
external magnetic field. From the figure we can conclude that the amount of drug deposition is
increasing with time steps and even the maximimum amount of the drug is near the targeted area
where the external magnetic field is created.

Fig 4.42 Total flux magnitude (mol/(m^2*s) variation along the blood vessel under external
magnetic field strength at different time steps t(Sec).
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Fig 4.43 Convective flux (mol/(m^2*s)) along the blood vessel under external magnetic field
strength.

Fig 4.44 Diffusive flux (mol/(m^2*s)) along the blood vessel under external magnetic field
strength.
Fig 4.42, 4.43, 4.44 shows different fluxes along the blood vessel under magnetic field
strength.
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4.5 Comparision
The total flux which is the sum of convective flux and diffusive flux deposited along the
blood vessel with and without magnetic fields are compared in the following figure

Fig 4.45 Bottom wall of the blood vessel where total flux of the drug is deposited.

A point near the tumour (80,-1,-1) is selected and concentration of drug deposited at that
point is calculatedformagnetic fields near the tumor and without magnetic field near the tumor.
The following fugures shows the amount of drug deposited near the tumor with and without
external magnetic fields. The figure clearly explains the amount of increase in drug deposition
under magnetic fields. Even we can see that amount of the total flux deposited at that point is
increasing with the time steps.
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Concentration@point(80,-1,-1)
0.01
0.009
0.008
0.007
0.006

Concentration with magnetic field

0.005
0.004

Concentration without magnetic filed

0.003
0.002
0.001
0
0

100

200

300

400

500

-0.001

Fig 4.46 Comparision of the amount of the drug deposited at point (80,-1,-1) near the tumor
location is plotted over the 500 time steps with magnetic fields and without magnetic fields.
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0

100

200

300

400

500

Fig 4.47Concentration of the drug deposited along the bottom wall of the blood vessel over 500
time steps is plotted with and without magnetic fields.
The above figures 4.46, 4.47 shows that concentration of the drugdeposited along the
bottom wall of the blood vessel under magnetic fields is much higher than the concentration of
drug deposited without magnetic fields. The figure shows that amount of drug deposited along the
blood vessel is varying along the time step but at every time step over all concentration of the drug
is increasing. But we have to note that this is the totalconcentration of the drug deposited along the
bottom wall of the blood vessel but the drug deposited near the tumor is increasing at every
timestep as we shown in previous results and graphs.
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Flux Deposited along the bottom blood vessel with and without magnetic field strength.

Fig 4.48 Total flux,convective flux and diffusive flux deposited on bottom wall of the blood
vessel without magnetic field

Fig 4.49 Shows all the fluxes under external magnetic field strength.
From above figures 4.47, 4.48, 4.49 we can say that the maximum amount of the flux
deposited along the bottom blood vessel with external magnetic field strength guiding the
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magnetic particles towards the tumor location is 40*10^-9[ mol/m^2*s] and without external
guiding force is 4.94*10^-11[ mol/m^2*s].
Table 4.1 Table of values
Under External Magnetic Field
Strength

Without Magnetic Field Stregth

Along the bottom

Along the bottom

blood vessel wall

Point (80,-1,-1)

blood vessel wall

Point (80,-1,-1)

13.6*10^-6

9.4*10^-3

6.37*10^-8

8.84*10^-4

Concentration
[mol/m^3]
Convective
Flux [
mol/m^2*s].

4.35*10^-8

4.94*10^-10

4.35*10^-8

4.94*10^-10

2.94*10^-11

8*10^-13

Total Flux
[mol/m^2*s]
Diffusive Flux
[mol/m^2*s]

Discussion of the values obtained:
The comparision of the values were shown in the above table by producing the magnetic
field stregth under the tumor and without the magnetic field as we discussed earlier. The values
are compared by considering a particular point (80,-1,-1) near the tumor and total volume of the
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drug deposited on the lower blood vessel wall uisng the equation discussed in chapter 3. Intaially
the concentration of the drug particle at point without magnetic fields is resulted as 8.84*10^-4
mol/m^3 but under external magnetic guiding force the concentration of the drug is increased to
9.4*10^-3 mol/m^3. The concentration of the drug particles along bottom blood vessel without
magnetic filed strength is calculated 6.37*10^-8 mol/m^3 and under magnetic filed stregth is
13.6*10^-6 mol/m^3. The total flux which is the sum of diffusive flux and convective flux is
focued because the diffusive flux is very low and negligible. The value of total flux is almost equal
to the convective flux this shows that the convective flux caused convective velocity of the
particles is highly dominated than the diffusive flux which is the sum of Brownian diffusion and
shear diffusion as we discussed in chapter 3.The total flux along the bottom blood vessel wall is
4.35*10^-8 [ mol/m^2*s] under external magnetic field strength and 4.94*10^-10[ mol/m^2*s]
without magnetic filed strength.

4.6 Effects of magnetic parameters on concentration
The concentration of the drug is varied under various external parameters like dipole
strength(m), angle of injection of the drug. The dipole strength is the major parameter on which
the magnetic filed vector is depends on. The following expression shows the relation between
dipole strength (m) and magnetic field vector(H)
1

𝑚

H= 2𝜋*𝑒 3
The above relation shows that dipole strength is directly proportional to magnetic field
strength through which the external guiding force is produced to drag the magnetic particles out
of the suspension. The higher the value of dipole strength magneic field strength is higher near the
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tumor location so the magnetic drug particles are guided towards the location as they were attracted
by the magnetic force also acts as guiding force. This is the reason the magnetic particles are highly
controlled inside the body by varying the field strength. The results are shown at different dipole
strength values.
Dipole moment Variation:

Fig 4.50 Concentration of the drug particles at m=5 A/m
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Fig 4.51 Concentration of the drug particles at m=50 A/m.
The figures 4.50, 4.51 shows the concentration of the drug around the tumour at different
dipole strengths.
0.01

Concentration at a point at m=5 & 50
A/m^2

0.009
0.008

@(80,-1,-1)

0.007
0.006
0.005

at m=5 A/m

0.004

at m= 50 A/m

0.003
0.002
0.001
0
0

10

20

30

40

50

60

Fig 4.52 Comparision of concentration of the particles at different dipole strengths.
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The values of the concentration of the drug particles at different dipole values at point
(80,-1,-1) are calculated and are plotted over different 50 time steps.The following figure
explains that the concentration of the drug particles is high as dipole moment value increases.
Angle of injection:
The another parameter which effects the concentration of the drug particles is the angle of
injection of the particles into the body.The following figure defines the angle of of injection.

Fig 4.53 Angle of Injection

(θ) Vs concentration at a point
0.025

0.02
0

0.015

30
45

0.01

60
0.005

0
0
-0.005

1

2

3

4

5

6

Time(s)

Fig4.54 Comparision of the concentration of the drug values over time steps at different angles
of injection.
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The magnetic force avtion on the particles is dependent on the angle of injection. From the
above figure we can see that intially there is not much variation in the concentration of the drug
particles but as the angle in inceased from 0 to 60 degress we can see maximum amount of
concentration of the drug particle near the tumor.
4.7 Conclusions


A three-dimensional computational simulation model for MDT based on coupled blood
flow dynamics and mass species transport in a blood flow artery network is developed to
simulate the delivery and deposition of the magnetic drug particles near the target region.



The flow field and drug concentration variations are analyzed under the influence of a
cardiac cycle to evaluate and demonstrate the effectiveness of the MDT method in
delivering the drugs to the tumor region.



Sensitivity of drug concentration and deposition is analyzed with varying key process and
magnetic field parameters such as the angular position of magnet and magnetic dipole
moment to optimized MDT method.

4.8 Future Work


Extend the model to include penetration of the dug particles into the tissue and tumor
regions.



Analyze effect of size of the drug particles.



Evaluate and identify other potential multifunctional magnetic drug particles
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